The circadian rhythm of caloric intake is less pronounced and more delayed in young individuals with overweight and obesity ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

As England's ever expanding obesity crisis is blamed for a drop in life expectancy MailOnline reveals the areas of the nation ...

HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...

Zealand Pharma achieved notable organizational growth in 2024 with a 30% increase in the number of employees compared to 2023 ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Children with overweight and obesity experienced notable improvements in health outcomes after participating in a lifestyle ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

A long-term study of 121,119 participants found that increasing olive oil intake was associated with less weight gain over ...

Weight loss associated with naltrexone-bupropion also led to a beneficial shift in body composition in individuals with ...

As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial ...